Vacuum clot removal for people with serious pulmonary embolism
Collects data on catheter clot removal in moderately to severely ill pulmonary embolism patients.
Key facts
- Who runs it
- University Hospital Plymouth NHS Trust
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Thrombectomy in Pulmonary Embolism
- Status
- Recruiting
- People taking part
- 2,000 people, planned
- Started
- 11 May 2026
- Expected to end
- 11 Dec 2029
- Type of study
- Observational, 2 groups
- Record updated
- 25 June 2026
Who can take part
The trial is looking for adults with a recent blood clot in the lung (pulmonary embolism) of intermediate or high risk, with signs of strain on the heart. It collects data on clot removal through a tube (CAVT thrombectomy) and other treatments.
- Age
- 18 years and older
- Sex
- All sexes can join
- Disease stage
- Acute pulmonary embolism confirmed by a CT scan, with symptoms for 14 days or less. It must be intermediate or high risk by European Society of Cardiology guidelines. The CT scan must be from within a two-year period.
- Biomarker or test result
- Signs the heart is not working well: blood test or imaging signs of strain on the right side of the heart.
- Main reasons for not taking part
- Known serious, uncontrolled reaction to contrast dyes used in X-ray imaging
- No CT scan available to check the clot
- Low-risk pulmonary embolism
- Taking part in another study of a test drug or device that may affect the results
- Other medical, social or mental health issues that stop consent or taking part in follow-up
Show the full registry criteria (20)Hide the full registry criteria
Who can take part
- Clinical signs and symptoms consistent with acute pulmonary embolism with duration of 14 days or less
- Patients who present with computed tomography confirmed pulmonary embolism
- Defined as intermediate or high-risk pulmonary embolism (according to European Society of Cardiology guidelines)
- Date of computed tomography imaging from within a two-year period
- Patient is greater than or equal to 18 years of age
- Informed consent obtained
- Evidence of cardiac dysfunction (either biochemical or imaging features of right heart strain)
- Clinical signs and symptoms consistent with acute PE with duration of 14 days or less
- Patients who present with CT confirmed PE
- Defined as intermediate or high-risk PE (according to ESC guidelines1)
- Date of CT imaging from within a two-year period
- Patient is ≥ 18 years of age
- Informed consent obtained
- Evidence of cardiac dysfunction (Either biochemical or imaging features of RHS)
Who cannot take part
- Current participation in another investigational drug or device study that may confound the results of this study. Studies requiring extended follow-up for products that were investigational but have since become commercially available are not considered investigational
- 1. Known serious, uncontrolled sensitivity to radiographic agents 2. CT not available to evaluate PE 3. Low Risk PE as defined by ESC guidelines1 4. Current participation in another investigational drug or device study that may confound the results of this study. Studies requiring extended follow-up for products that were investigational but have since become commercially available are not considered investigational studies 5. Other medical, social, or psychological conditions that, in the opinion of the Investigator, precludes the patient from appropriate consent, could limit the patient's ability to participate in the study, including compliance with follow-up requirements, or that could impact the scientific integrity of the study
- Other medical, social, or psychological conditions that, in the opinion of the investigator, preclude the patient from appropriate consent, could limit the patient's ability to participate in the study, including compliance with follow-up requirements, or that could impact the scientific integrity of the study
- Known serious, uncontrolled sensitivity to radiographic agents
- Computed tomography not available to evaluate pulmonary embolism
- Low-risk pulmonary embolism as defined by European Society of Cardiology guidelines
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Pulmonary embolism and thrombosis
This trial is currently available in United Kingdom.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Pulmonary embolism is a blood clot on the lung, which can cause death or significant reduced quality of life. Sucking the clot out with a special tube (catheter) is a relatively new procedure that can be performed but doesn't have the data required to properly support its use in some patients. We know this procedure works in patients who have no other options and would almost certainly die without intervention. We currently don't know how well this procedure is tolerated, how well it works and what its complications are in patients who are moderately to severely unwell. The National Institute of Clinical Excellence (NICE), an advisory body, suggests more data is required to support its use in patients who are sick or very sick. This registry aims to support this growing evidence base to workout if the treatment is effective and the associated risks that come with using it. We are collecting data about this procedure and other treatments patients get offered to better inform clinicians and researchers.
The 2 groups in the trial
- CAVT thrombectomy
PE with evidence of right heart strain and thrombectomy with 16Fr CAVT
- PE with evidence of right heart strain
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Prospective Observational Study to Evaluate the Use of Computer-Aided Vacuum Thrombectomy Within the Context of Intermediate and High-Risk Pulmonary Embolism
- Plain-language title
- Vacuum clot removal for people with serious pulmonary embolismGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT07650435, who can take part
- Record updated
- 25 June 2026